naftopidil has been researched along with silodosin in 36 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (16.67) | 29.6817 |
| 2010's | 27 (75.00) | 24.3611 |
| 2020's | 3 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Li, MY; Tsai, KC; Xia, L | 1 |
| Kobayashi, K; Kobayashi, M; Maruyama, I; Shibata, N; Tatemichi, S; Yamazaki, Y | 1 |
| Hayashi, M; Kobayashi, M; Kobayashi, S; Shibata, N; Tadachi, M; Tatemichi, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Kobayashi, K; Kobayashi, M; Kobayashi, S; Maezawa, A; Maruyama, I; Shibata, N; Tatemichi, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Noguchi, Y; Ohtake, A; Sasamata, M; Suzuki, M | 1 |
| Aizawa, N; Andersson, KE; Chen, Z; Igawa, Y; Imamura, T; Ishizuka, O; Nishizawa, O | 1 |
| Hoyano, Y; Kobayashi, S; Kohri, K; Sasaki, S; Tomiyama, Y; Yamazaki, Y | 1 |
| Fujii, T; Fukumoto, K; Hara, R; Jo, Y; Miyaji, Y; Nagai, A; Sone, A; Yokoyama, T | 1 |
| Baba, S; Fujita, T; Hayakawa, K; Ishiyama, H; Kimura, M; Kitano, M; Kotani, S; Matsumoto, K; Minamida, S; Satoh, T; Tabata, K; Tsumura, H | 1 |
| Homma, Y; Kaneko, T; Matsushima, H; Tsuzaka, Y; Yamaguchi, T | 1 |
| Ashitomi, K; Kadekawa, K; Nishijima, S; Sugaya, K; Yamamoto, H | 1 |
| Hoyano, Y; Kobayashi, K; Kobayashi, M; Kuroda, J; Kusama, H; Maruyama, K; Tatemichi, S; Yokoi, R | 1 |
| Dimitriadis, F; Kinoshita, Y; Ohmasa, F; Oikawa, R; Saito, M; Satoh, K; Shimizu, S; Tsounapi, P | 1 |
| Fujisawa, M; Haraguchi, T; Minayoshi, K; Miyake, H; Miyazaki, J; Morishita, S; Shigemura, K; Shirakawa, T; Tanaka, K; Yamada, Y | 1 |
| Asakura, T; Hashiba, T; Jinza, S; Masuda, M; Masuko, H | 1 |
| Aoki, Y; Hachiya, T; Saito, T; Takahashi, S; Yamaguchi, K; Yoshikawa, T | 1 |
| Araki, M; Araki, T; Monden, K | 1 |
| Anai, S; Asakawa, I; Fujimoto, K; Hasegawa, M; Hirayama, A; Konishi, N; Miyake, M; Tanaka, N; Torimoto, K | 1 |
| Creta, M; Ficarra, V; Fusco, F; Giannarini, G; Longo, N; Mirone, V; Novara, G; Palmieri, A; Verze, P | 1 |
| Funahashi, Y; Gotoh, M; Kato, M; Majima, T; Matsukawa, Y; Narita, H; Ogawa, T; Takai, S | 1 |
| Carson, CC | 1 |
| Amano, T; Araki, T; Haga, K; Honma, I; Kondou, N; Matsukawa, M; Otani, T; Sato, Y; Tobe, M; Uchida, K | 1 |
| Fukuhara, S | 1 |
| Seftel, AD | 1 |
| Dahm, P; Jung, JH; Kim, J; Kim, MH; MacDonald, R; Reddy, B | 1 |
| Gandhi, S; Hwang, EC; Jung, JH | 1 |
| Haga, K; Hirose, T; Ichihara, K; Iwasawa, A; Masumori, N; Miyao, N; Nishimura, M; Sasamura, H; Suzuki, N; Taguchi, K; Yamaguchi, Y | 1 |
| Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R | 1 |
| Kubono, S; Kuramoto, K; Mizutani, H; Takahashi, H; Tanaka, N; Taneyama, T; Yoshida, M | 1 |
| Fujimura, M; Fukui, T; Oka, M; Oyama, T; Yoshifuji, M; Yoshinaga, R | 1 |
| Miernik, A; Praus, F | 1 |
| Funahashi, Y; Gotoh, M; Kato, M; Majima, T; Matsukawa, Y; Takai, S | 1 |
| Anai, S; Asakawa, I; Fujii, T; Fujimoto, K; Hasegawa, M; Maesaka, F; Miyake, M; Nakai, Y; Owari, T; Tanaka, N; Tomizawa, M; Yamaki, K | 1 |
| Kadono, Y | 1 |
| Kawakami, Y; Kotake, K; Noritake, Y | 1 |
5 review(s) available for naftopidil and silodosin
| Article | Year |
|---|---|
α1-Blockers Improve Benign Prostatic Obstruction in Men with Lower Urinary Tract Symptoms: A Systematic Review and Meta-analysis of Urodynamic Studies.
Topics: Adrenergic alpha-1 Receptor Antagonists; Clinical Trials as Topic; Doxazosin; Humans; Indoles; Male; Naphthalenes; Piperazines; Prazosin; Prostatism; Quinazolines; Severity of Illness Index; Sulfonamides; Tamsulosin; Urodynamics | 2016 |
Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Randomized Controlled Trials as Topic; Urological Agents | 2017 |
New alpha blockers to treat male lower urinary tract symptoms.
Topics: Adrenergic alpha-Antagonists; Ejaculation; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quality of Life; Treatment Outcome; Urological Agents | 2018 |
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Plant Extracts; Prostatic Hyperplasia; Prostatism; Quality of Life; Randomized Controlled Trials as Topic; Sulfonamides; Tamsulosin; Urological Agents | 2018 |
[LUTS in BPH patients : Comparison of silodosin versus tamsulosin, naftopidil, alfuzosin and placebo for the treatment of lower urinary tract symptoms].
Topics: Adrenergic alpha-1 Receptor Antagonists; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Quinazolines; Tamsulosin; Treatment Outcome; Urological Agents | 2019 |
12 trial(s) available for naftopidil and silodosin
| Article | Year |
|---|---|
Effects of three types of alpha-1 adrenoceptor blocker on lower urinary tract symptoms and sexual function in males with benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Ejaculation; Erectile Dysfunction; Humans; Indoles; Male; Middle Aged; Naphthalenes; Patient Satisfaction; Piperazines; Prostatic Hyperplasia; Sulfonamides; Surveys and Questionnaires; Tamsulosin; Urination; Urination Disorders | 2011 |
Comparison of prophylactic naftopidil, tamsulosin, and silodosin for 125I brachytherapy-induced lower urinary tract symptoms in patients with prostate cancer: randomized controlled trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Analysis of Variance; Brachytherapy; Humans; Indoles; Iodine Radioisotopes; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Prostatic Neoplasms; Quality of Life; Radiotherapy Dosage; Sulfonamides; Tamsulosin | 2011 |
Naftopidil vs silodosin in medical expulsive therapy for ureteral stones: a randomized controlled study in Japanese male patients.
Topics: Adrenergic alpha-Antagonists; Adult; Humans; Indoles; Japan; Lithotripsy; Male; Middle Aged; Naphthalenes; Piperazines; Time Factors; Ureteral Calculi | 2011 |
Silodosin versus naftopidil in Japanese patients with lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized multicenter study.
Topics: Adrenergic alpha-Antagonists; Aged; Asian People; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prostate; Prostatic Hyperplasia; Treatment Outcome; Urological Agents | 2013 |
[Comparison of naftopidil and silodosin in the treatment of male lower urinary tract symptoms associated with benign prostatic hyperplasia: a randomized, crossover study].
Topics: Adrenergic alpha-Antagonists; Cross-Over Studies; Humans; Indoles; Male; Naphthalenes; Piperazines; Prostatic Hyperplasia; Urination Disorders | 2012 |
Silodosin versus naftopidil for the treatment of benign prostatic hyperplasia: a multicenter randomized trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Ejaculation; Humans; Indoles; Kallikreins; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prostate-Specific Antigen; Prostatic Hyperplasia; Quality of Life; Sexual Behavior; Therapeutics | 2013 |
Comparison of 7 α(1)-adrenoceptor antagonists in patients with lower urinary tract symptoms associated with benign prostatic hyperplasia:a short-term crossover study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Cross-Over Studies; Doxazosin; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Middle Aged; Naphthalenes; Piperazines; Prazosin; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Treatment Outcome | 2013 |
Use of alpha-1 adrenoceptor antagonists in patients who underwent low-dose-rate brachytherapy for prostate cancer - a randomized controlled trial of silodosin versus naftopidil.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Brachytherapy; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prostatic Neoplasms; Urinary Bladder, Overactive | 2014 |
Comparison of Silodosin and Naftopidil for Efficacy in the Treatment of Benign Prostatic Enlargement Complicated by Overactive Bladder: A Randomized, Prospective Study (SNIPER Study).
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Receptors, Adrenergic, alpha-1; Treatment Outcome; Urinary Bladder, Overactive; Urination; Urodynamics | 2017 |
Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies; Self Administration; Time Factors; Treatment Outcome; Urological Agents; Young Adult | 2017 |
What Are Factors Contributing to Improvement of Overactive Bladder Symptoms after Alpha-1 Blocker Treatment in Patients with Both Storage and Voiding Symptoms?
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Male; Middle Aged; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Treatment Outcome; Urinary Bladder, Overactive | 2019 |
Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.
Topics: Brachytherapy; Humans; Indoles; Male; Naphthalenes; Piperazines; Prostatic Neoplasms; Quality of Life | 2021 |
19 other study(ies) available for naftopidil and silodosin
| Article | Year |
|---|---|
Pharmacophore identification of alpha(1A)-adrenoceptor antagonists.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Drug Evaluation, Preclinical; Expert Systems; Humans; Models, Molecular; Receptors, Adrenergic, alpha-1; Software; Structure-Activity Relationship | 2005 |
[Effects of silodosin (KMD-3213) on phenylephrine-induced increase in intraurethral pressure and blood pressure in rats--study of the selectivity for lower urinary tract].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dose-Response Relationship, Drug; Heart Rate; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Rats; Sulfonamides; Tamsulosin; Urethra | 2006 |
[Effect of silodosin on intraurethral pressure increase induced by hypogastric nerve stimulation in dogs with benign prostatic hyperplasia].
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Hypogastric Plexus; Indoles; Male; Naphthalenes; Piperazines; Pressure; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra | 2006 |
Uroselectivity in male dogs of silodosin (KMD-3213), a novel drug for the obstructive component of benign prostatic hyperplasia.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Carotid Artery, Common; Data Interpretation, Statistical; Dogs; Electric Stimulation; Heart Rate; Hypogastric Plexus; In Vitro Techniques; Indoles; Male; Naphthalenes; Norepinephrine; Organ Specificity; Piperazines; Prostate; Prostatic Hyperplasia; Sulfonamides; Tamsulosin; Urethra; Urethral Obstruction; Urinary Tract | 2006 |
In vivo study on the effects of alpha1-adrenoceptor antagonists on intraurethral pressure in the prostatic urethra and intraluminal pressure in the vas deferens in male dogs.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Animals; Dogs; Dose-Response Relationship, Drug; Ejaculation; Indoles; Male; Naphthalenes; Phenylephrine; Piperazines; Prazosin; Pressure; Prostate; Quinazolines; Sulfonamides; Tamsulosin; Urethra; Vas Deferens | 2008 |
Role of alpha1-adrenergic receptors in detrusor overactivity induced by cold stress in conscious rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Animals; Blood Pressure; Body Temperature; Cold Temperature; Female; Indoles; Naphthalenes; Piperazines; Prazosin; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Sulfonamides; Tamsulosin; Urinary Bladder; Urinary Bladder, Overactive | 2009 |
Effects of silodosin and naftopidil on the distal ureter and cardiovascular system in anesthetized dogs: comparison of potential medications for distal ureteral stone passage.
Topics: Adrenergic alpha-Antagonists; Anesthesia; Animals; Cardiovascular System; Dogs; Dose-Response Relationship, Drug; Indoles; Male; Naphthalenes; Piperazines; Ureter; Ureteral Calculi | 2010 |
Excitatory effect of propiverine hydrochloride on urethral activity in rats.
Topics: Adrenergic alpha-Antagonists; Animals; Benzilates; Female; Imidazoles; Indoles; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Naphthalenes; Piperazines; Prazosin; Pressure; Rats; Rats, Sprague-Dawley; Urethra; Urinary Bladder | 2012 |
Comparison of the effects of four α1-adrenoceptor antagonists on ejaculatory function in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Indoles; Male; Naphthalenes; Piperazines; Quinazolines; Rats; Rats, Sprague-Dawley; Sulfonamides; Tamsulosin | 2012 |
Characterization of silodosin and naftopidil in the treatment of bladder dysfunction in the spontaneously hypertensive rat.
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Blood Pressure; Body Weight; Circadian Rhythm; Indoles; Male; Muscle Contraction; Naphthalenes; Organ Size; Piperazines; Rats; Rats, Inbred SHR; Rats, Wistar; Urinary Bladder; Urinary Bladder Diseases; Urination | 2013 |
Editorial Comment.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Prospective Studies; Urinary Bladder, Overactive | 2017 |
Editorial Comment to Silodosin versus naftopidil in the treatment of premature ejaculation: A prospective multicenter trial.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies | 2017 |
Topics: Adrenergic alpha-Antagonists; Humans; Indoles; Naphthalenes; Piperazines; Prospective Studies; Urinary Bladder, Overactive | 2017 |
Re: Silodosin versus Naftopidil in the Treatment of Premature Ejaculation: A Prospective Multicenter Trial.
Topics: Humans; Indoles; Male; Naphthalenes; Piperazines; Premature Ejaculation; Prospective Studies | 2017 |
Silodosin as second-line α-blocker monotherapy in patients with benign prostatic hyperplasia: A prospective observational study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Humans; Indoles; Lower Urinary Tract Symptoms; Male; Naphthalenes; Piperazines; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Severity of Illness Index; Tamsulosin; Treatment Outcome | 2018 |
Post-Marketing Surveillance of Silodosin in Patients with Benign Prostatic Hyperplasia and Poor Response to Existing Alpha-1 Blockers: The SPLASH Study.
Topics: Adrenergic alpha-1 Receptor Antagonists; Aged; Aged, 80 and over; Epidemiological Monitoring; Humans; Indoles; Japan; Male; Middle Aged; Naphthalenes; Piperazines; Product Surveillance, Postmarketing; Prospective Studies; Prostatic Hyperplasia; Quality of Life; Surveys and Questionnaires; Tamsulosin; Treatment Outcome | 2019 |
Comparison of the Effects of Tadalafil and α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Ejaculation; Electric Stimulation; Indoles; Male; Muscle Contraction; Naphthalenes; Phosphodiesterase 5 Inhibitors; Piperazines; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Seminal Vesicles; Tadalafil; Tamsulosin; Vas Deferens | 2019 |
Editorial Comment to Comparison of disease-specific quality of life in prostate cancer patients treated with low-dose-rate brachytherapy: A randomized controlled trial of silodosin versus naftopidil.
Topics: Brachytherapy; Humans; Indoles; Male; Naphthalenes; Piperazines; Prostatic Neoplasms; Quality of Life | 2021 |
Association of silodosin, tamsulosin, and naftopidil with delirium: analysis of the pharmacovigilance database in Japan.
Topics: Adrenergic Agonists; Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-Antagonists; Cholinergic Antagonists; Delirium; Humans; Japan; Male; Pharmacovigilance; Prostatic Hyperplasia; Tamsulosin | 2023 |